NZ320237A - Stable pharmaceutical forms of administration containing parathormone - Google Patents

Stable pharmaceutical forms of administration containing parathormone

Info

Publication number
NZ320237A
NZ320237A NZ320237A NZ32023796A NZ320237A NZ 320237 A NZ320237 A NZ 320237A NZ 320237 A NZ320237 A NZ 320237A NZ 32023796 A NZ32023796 A NZ 32023796A NZ 320237 A NZ320237 A NZ 320237A
Authority
NZ
New Zealand
Prior art keywords
parathormone
pharmaceutical forms
stable pharmaceutical
administration containing
parathyroid hormone
Prior art date
Application number
NZ320237A
Inventor
Bueren Hendrik Von
Rolf-Dieter Gabel
Wolfgang Rodel
Heinrich Woog
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of NZ320237A publication Critical patent/NZ320237A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Abstract

Pharmaceutical preparations in the form of a lyphilisate or injection or infusion solution and that are stable during storage contain a parathyroid hormone or parathyroid hormone fragment as an active substance and a basic amino acid and optionally an organic or inorganic physiologically tolerated acid. The preparations are free of physiologically tolerated antioxidants.
NZ320237A 1995-10-17 1996-10-17 Stable pharmaceutical forms of administration containing parathormone NZ320237A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19538687A DE19538687A1 (en) 1995-10-17 1995-10-17 Stable pharmaceutical dosage forms containing parathyroid hormone
PCT/EP1996/004503 WO1997014429A1 (en) 1995-10-17 1996-10-17 Stable pharmaceutical forms of administration containing parathormone

Publications (1)

Publication Number Publication Date
NZ320237A true NZ320237A (en) 1999-11-29

Family

ID=7775105

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ320237A NZ320237A (en) 1995-10-17 1996-10-17 Stable pharmaceutical forms of administration containing parathormone

Country Status (14)

Country Link
EP (1) EP0855917A1 (en)
JP (1) JPH11515002A (en)
KR (1) KR19990064322A (en)
AU (1) AU7294196A (en)
BR (1) BR9610983A (en)
CA (1) CA2234724A1 (en)
CZ (1) CZ108398A3 (en)
DE (1) DE19538687A1 (en)
HU (1) HUP9900751A3 (en)
NZ (1) NZ320237A (en)
SK (1) SK47298A3 (en)
TR (1) TR199800690T1 (en)
WO (1) WO1997014429A1 (en)
ZA (1) ZA968715B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19539574A1 (en) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Preparations and processes for stabilizing biological materials by means of drying processes without freezing
DE19716154A1 (en) * 1997-04-18 1998-10-22 Boehringer Mannheim Gmbh Stable pharmaceutical dosage form for peptides, proteins and nucleic acids
ZA9811127B (en) † 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
SE9801495D0 (en) * 1998-04-28 1998-04-28 Astra Ab Protein formulation
AU1189301A (en) * 1999-10-29 2001-05-14 Eli Lilly And Company A pharmaceutical composition having high cell membrane permeability
BR0108173A (en) * 2000-02-08 2003-01-21 Allergan Inc Botulinum toxin pharmaceutical compositions
AR032461A1 (en) * 2000-06-30 2003-11-12 Daiichi Asubio Pharma Co Ltd PHARMACEUTICAL COMPONENT THAT INCLUDES A PEPTIDE OF HUMAN PARTIROID HORMONE OR ITS DERIVATIVE AND ACETIC ACID, PHARMACEUTICAL COMPOSITION FOR INTRANASAL ADMINISTRATION THAT INCLUDES SUCH COMPONENT, AND PHARMACEUTICAL PRODUCT THAT INCLUDES SUCH COMPONENT
EP1598074B1 (en) 2003-02-28 2019-01-02 Chugai Seiyaku Kabushiki Kaisha Stabilized protein-containing formulations
WO2005014034A1 (en) * 2003-07-14 2005-02-17 Nps Allelix Corp. Stabilized formulation of parathyroid hormone
KR100700869B1 (en) * 2005-06-03 2007-03-29 재단법인 목암생명공학연구소 The stabilized parathyroid hormone composition comprising parathyroid hormone buffer and stabilizing agent
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
FR2947181B1 (en) * 2009-06-26 2012-05-04 Lfb Biotechnologies FACTOR VII COMPOSITION
KR20150116468A (en) 2011-06-07 2015-10-15 아사히 가세이 파마 가부시키가이샤 Freeze-dried preparation containing high-purity pth and method for producing same
BR112017023233A2 (en) 2015-04-29 2018-11-06 Radius Pharmaceuticals Inc methods for cancer treatment
JP6634758B2 (en) * 2015-09-25 2020-01-22 ニプロ株式会社 Liquid composition and freeze-dried preparation
AU2018205285C1 (en) 2017-01-05 2023-08-24 Radius Pharmaceuticals, Inc. Polymorphic forms of RAD1901-2HCl
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
WO2019059302A1 (en) * 2017-09-22 2019-03-28 旭化成ファーマ株式会社 Teriparatide-containing liquid pharmaceutical composition having excellent stability
CA3104395A1 (en) 2018-07-04 2020-01-09 Radius Pharmaceuticals, Inc. Polymorphic forms of rad1901-2hcl
WO2021229835A1 (en) * 2020-05-11 2021-11-18 旭化成ファーマ株式会社 Stable liquid pharmaceutical preparation containing teriparatide or salt thereof
JP6947946B1 (en) * 2020-05-11 2021-10-13 旭化成ファーマ株式会社 Stable liquid pharmaceutical product containing teriparatide or a salt thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
JP2739482B2 (en) * 1988-08-11 1998-04-15 バイオ・チバ株式会社 Method for producing stable calcitonin injection
JPH0341033A (en) * 1989-07-07 1991-02-21 Kyowa Hakko Kogyo Co Ltd Stable preparation containing motilins
WO1993011785A1 (en) * 1991-12-09 1993-06-24 Asahi Kasei Kogyo Kabushiki Kaisha Stabilized parathyroid hormone composition
DE4203040A1 (en) * 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh NEW PARATHORMON FRAGMENTS, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THEM

Also Published As

Publication number Publication date
SK47298A3 (en) 1998-11-04
TR199800690T1 (en) 1998-06-22
HUP9900751A3 (en) 2000-07-28
BR9610983A (en) 1999-03-02
CZ108398A3 (en) 1998-09-16
JPH11515002A (en) 1999-12-21
WO1997014429A1 (en) 1997-04-24
EP0855917A1 (en) 1998-08-05
ZA968715B (en) 1998-04-16
KR19990064322A (en) 1999-07-26
DE19538687A1 (en) 1997-04-24
HUP9900751A2 (en) 1999-07-28
AU7294196A (en) 1997-05-07
CA2234724A1 (en) 1997-04-24

Similar Documents

Publication Publication Date Title
NZ320237A (en) Stable pharmaceutical forms of administration containing parathormone
EP0783299A4 (en) Compounds and compositions for delivering active agents
DE69637961D1 (en) ADMINISTRATION OF BIOLOGICALLY ACTIVE POLYPEPTIDES
ATE200025T1 (en) LIQUID MEDICINAL PREPARATIONS CONTAINING THYROID HORMONES
HK1097449A1 (en) Methods for in vivo delivery of biologics and compositions useful therefor
ATE234602T1 (en) ADMINISTRATION FORM FOR THE DELIVERY OF INCREASING DOSES OF ACTIVE INGREDIENTS
HU9503085D0 (en) Veterinary composition containing a proton pump inhibitor
NZ236823A (en) Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance
GR3026376T3 (en) Drug delivery system and method of making the same.
ES2126536B1 (en) "PHARMACEUTICAL PREPARATION FOR INTRANASAL ADMINISTRATION AND PROCEDURE FOR ITS PRODUCTION".
GR3036622T3 (en) Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
ATE298561T1 (en) ORAL DOSAGE FORM
HU912990D0 (en) Medical preparation
PT768867E (en) DOSAGE FORM FOR THE ADMINISTRATION OF DRUG IN LIQUID FORMULATION
GEP20002229B (en) Synthetic Membrane Vesicles, Method for Obtaining and Application of the Same
AU2084801A (en) Antiviral medication
DK0996462T3 (en) Combination pharmaceutical preparations containing erythropoietin and modified hemoglobins
DK0684812T3 (en) Condensed-phase microparticle preparation and method
PL348202A1 (en) Pharmaceutically active composition and dispensing device
ES2024729A6 (en) Composition and treatment with biologically active peptides and certain anions.
GR3033445T3 (en) Molecular transdermal transport system
HK1029277A1 (en) Pharmaceutical coating composition and method of use.
MY103532A (en) A liquid dosage form for oral administration of a pharmaceutically active substance
JO1881B1 (en) Multiple unit tableted dosage from ii
GEP20002312B (en) Ointment for Treatment of Osteoarticular System with Herbs